Trelegy ellipta 100-62.5-25 60S
Ended Awarded Last action
- Contract number
- SPE2DR26F6V3L
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $6,442
Award facts
- Contract value 100% obligated
- $6,442.37 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 22, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalers (60-count units) with a contract value of $6,442.37 and a firm fixed price structure. This delivery order represents a non-set-aside, competitively awarded transaction executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026. The pharmaceutical will be sourced from AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania, where the company operates as a major healthcare solutions provider specializing in federal medical procurement for military and veteran healthcare systems.
Trelegy Ellipta is a combination inhaler used for chronic obstructive pulmonary disease management, reflecting the breadth of therapeutic products AmerisourceBergen supplies through its DLA contract portfolio. This transaction exemplifies the company's role as a critical pharmaceutical distributor within the Defense Health Agency's medical supply chain, fulfilling recurring federal medical needs through flexible delivery order mechanisms. AmerisourceBergen's comprehensive IDC vehicle enables the company to respond efficiently to episodic procurement requirements across multiple therapeutic domains while maintaining firm fixed pricing and supporting military healthcare operations globally.
Quick answers
Who was awarded contract SPE2DR26F6V3L?
SPE2DR26F6V3L was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 22, 2025.
How much is contract SPE2DR26F6V3L worth?
The government has obligated $6,442 on SPE2DR26F6V3L.
Is contract SPE2DR26F6V3L an order under another contract?
Yes. SPE2DR26F6V3L is a delivery order under SPE2DR25D3013, an indefinite delivery contract.
Was contract SPE2DR26F6V3L competed?
The extent of competition for SPE2DR26F6V3L was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award